On September 10, Governor Andrew M. Cuomo announced that $2.3 million in federal CARES Act funding was awarded to four organizations providing critical services to small and mid-sized manufacturers, to help them adapt to changing market conditions during the COVID-19 pandemic. The awardees, which are New York Manufacturing Extension Partnership centers designated by Empire State Development, will use the funds to assist companies in re-shoring and rebuilding supply chains, securing personal protective equipment, improving safety and efficiency, adopting new technologies, and enhancing resilience for future disruptions.

Newlab was among the funding recipients of this round of CARES Act funding, through its collaboration with FuzeHub, an organization that champions and supports the New York State manufacturing and technology community. The funding will allow the Newlab venture, Spiro Devices, to continue developing innovative solutions in response to COVID-19 and future crises. Learn more about how Spiro Devices developed an emergency bridge ventilator to address ventilator shortages in hospitals in just 30 days.

Spiro Devices 

Spiro Devices was developed and launched through Newlab’s Venture Studio at the height of COVID-19 pandemic, with the goal of tackling the ventilator shortage

Newlab assembled engineers to evaluate the challenge and enlisted 55+ people, including member company 10xBeta and partner Boyce Technologies, to rapidly design, prototype, and obtain FDA approval for an MIT-inspired device in 30 days. The innovation sprint led to a 3,000 device order by the City of New York as backup bridge ventilators for the NYC Healthcare System.